Eribulin Mesylate

Eribulin Mesylate is used in the treatment of metastatic breast cancer. It is used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other anticancer medicines after the cancer has spread.

Eribulin Mesylate is an anticancer medication. It works by interfering with the microtubule structures which help the cancer cells to divide and multiply. This blocks the growth cycle (cell cycle) of cancer cells and eventually kills them.

Anemia (low number of red blood cells), Weakness, Hair loss, Nausea, Constipation, Decreased white blood cell count, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand)